Practitioner 2011; 255 (1737): 7-12
Epididymo-orchitis managed syndromically in primary care
21 Feb 2011
AUTHORS
Dr Richard Ma
GP principal, North London and staff grade in sexual and reproductive health, Margaret Pyke Centre, London
Article
Many men presenting with epididymo-orchitis in general practice are being prescribed antibiotics but not undergoing investigation, a large UK study has found.
Information from the General Practice Research Database (GPRD), which contains anonymised longitudinal patient records from 460 general practices, was used to estimate the incidence of epididymo-orchitis in primary care between 2003 and 2008 and examine the management of patients with this condition.
Men aged 15-60 years presenting with a first episode of epididymo-orchitis between 30th June 2003 and 30th June 2008 were included. Aspects of management assessed included: testing for STIs or UTIs, treatment using specific antibiotics for epididymo-orchitis, evidence of referral for further care or management only within the practice.
A total of 12,615 patients, median age 37 years, with a first episode of epididymo-orchitis were identified. The incidence was highest in 2004-2005 and declined in the later years of the study. The fall in incidence coincided with the roll out of the National Chlamydia Screening Programme but a causal link cannot be substantiated by this study.
Overall 57% of patients were managed entirely in general practice. Of these, 92% received an antibiotic; 56% received an antibiotic recommended for epididymo-orchitis and 29% an antibiotic recommended for UTI but not for epididymo-orchitis. Ciprofloxacin (36%) was the most commonly prescribed antibiotic; only 18% received doxycycline.
Most men had no investigations. Only 9% had any type of microbial test: less than 3% had a test for chlamydia and less than 0.1% a test for gonorrhoea. Around 22% had a urine test.
The incidence of acute epididymitis, with or without testicular involvement, is estimated to be around 40/10,000 person years in the UK. In men under 35, the likely pathogen is an STI such as chlamydia or gonorrhoea; in older men, this is likely to be due to non-sexually transmitted infections. Just under half of cases may have no identifiable cause. Effective treatment is important to avoid complications such as infertility, prostatitis and urethral strictures. Cases related to STIs present opportunities for partner notification.
The authors noted a surprising incidence of men over 35 with epididymo-orchitis and further research is recommended to understand the aetiology in this group.
That so many cases were managed syndromically, i.e. without investigations, is a cause for concern.
Dr Richard Ma
